Document is current
Any future updates will be listed below
-
Authors
Kodali, Nilesh
Diaz, DeAnna
Dhiman, Rohan
Vazquez, Thomas
Feng, Rui
Patel, Jay
Dan, Joshua
Sprow, Grant
Kleitsch, Julianne
Sharma, Meena
Bashir, Muhammad
Werth, Victoria P.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct03813160 at ClinicalTrials.govDocuments that mention this clinical trial
Diverse Lenabasum pathway activation in dermatomyositis patients’ blood
https://doi.org/10.1038/s41598-025-92001-z
-
Funding
Funding for this research was provided by:
National Institutes of Health (R21AR066286)
Penn Skin Biology and Diseases Resource-based Center, University of Pennsylvania (P30AR069589-01)
U.S. Department of Veterans Affairs (1I01BX005921)
- License Information
-
More Information
Article History
Received: 1 May 2024
Accepted: 25 February 2025
First Online: 18 May 2025
Declarations
:
: Our study, conducted at the University of Pennsylvania, adhered to the Declaration of Helsinki guidelines and was approved by the Institutional Review Board (IRB). The IRB protocol number is 808230.
: Written informed consent was obtained from each participant for publications of their details.
: The authors declare no competing interests.
